Matthew B. Boxer
Verax Biomedical (United States)(US)National Center for Advancing Translational Sciences(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Microtubule and mitosis dynamics, Biochemical and Molecular Research, Asymmetric Synthesis and Catalysis, Epigenetics and DNA Methylation
Most-Cited Works
- → Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses(2011)1,171 cited
- → Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis(2012)816 cited
- → Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors(2016)598 cited
- → A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate(2016)578 cited
- → Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery(2016)512 cited
- → Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo(2015)417 cited
- → High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells